| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| USRE38628 | ALLERGAN | Pharmaceutical compositions |
Aug, 2012
(11 years ago) | |
Alocril is owned by Allergan.
Alocril contains Nedocromil Sodium.
Alocril has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Alocril are:
- USRE38628
Alocril was authorised for market use on 08 December, 1999.
Alocril is available in solution/drops;ophthalmic dosage forms.
Alocril can be used as a method of treatment of a condition involving an antibody antigen reaction.
The generics of Alocril are possible to be released after 22 August, 2012.
Drugs and Companies using NEDOCROMIL SODIUM ingredient
Market Authorisation Date: 08 December, 1999
Treatment: A method of treatment of a condition involving an antibody antigen reaction
Dosage: SOLUTION/DROPS;OPHTHALMIC
More Information on Dosage
ALOCRIL family patents
